The preliminary findings of our pilot study suggest that in the gestational diabetes mellitus group, the ADIPOQ rs266729 polymorphism in newborns is not associated with higher birth weight, the maternal fasting glucose levels between 24 and 28 WG are a predictor for macrosomia, and cord blood adiponectin levels are lower than those from control mothers. Here, ADIPOQ is linked to gestational diabetes.